- Cash on hand was $14.4 million with $41.2 million drawn on the revolving credit line, and net debt to adjusted EBITDA was 0.38x.
- GAAP diluted EPS was $0.20 and adjusted diluted EPS was $0.27 for the quarter.
- Home Health and Hospice segment revenue increased 32.5% to $166 million with adjusted EBITDA up 29.9% to $25.5 million.
- Home Health revenue rose 28.5% to $79.2 million, with total admissions up 26.1% and Medicare admissions up 21.6%.
- Hospice revenue grew 24.3% to $73.8 million, with hospice admits up 14.7% and average daily census up 21.4%.
- Pennant Group reported Q2 2025 revenue of $219.5 million, up 30.1% year-over-year, and adjusted EBITDA of $16.4 million, up 24.5%.
- Senior Living segment revenue increased 23.1% to $53.5 million and adjusted EBITDA rose 25.7% to $5.1 million.
Related items and other data are not available for this feed item.
Dafinchi